Prenatal
CMA is offered prenatally if one or more of the below indications are presentb>
-
chevron_rightAbnormal fetal ultrasound
-
chevron_rightAbnormal NIPT results indicated an increased risk of a chromosomally
-
chevron_rightabnormal fetus
-
chevron_rightAbnormal high-risk maternal serum screen
-
chevron_rightThe parents have a known chromosomal rearrangement, mosaicism or
-
chevron_rightprevious aneuploidies
-
chevron_rightThe parents have had previous live births or stillbirths with chromosomal abnormalities
-
chevron_rightFetal congenital abnormalities detected with ultrasound or MRI that indicate a significant risk of an unbalanced chromosomal abnormality
-
chevron_rightApparently balanced inherited rearrangements in a fetus with congenital abnormalities.
-
chevron_rightApparently balanced de novo rearrangements identified by G-band analysis (karyotype)
-
chevron_rightHigh risk pregnancies
The CMA can be used in cases where other tests have failed to yield a diagnosis specifically if one or more of the below symptoms or conditions are present
-
chevron_rightUnexplained seizure disorder
-
chevron_rightGrowth delay
-
chevron_rightPsychiatric illness
-
chevron_rightNeuromuscular conditions
-
chevron_rightNeurodevelopmental conditions
-
chevron_rightSkeletal dysplasia
-
chevron_rightShort stature
-
chevron_rightExcessive growth
-
chevron_rightMicrocephaly
-
chevron_rightMacrocephaly